One of the most widely-read and highly-cited journals in the field of urology recently featured the TULSA-PRO system used at Busch Center. A study analyzing the treatment of 115 men using TULSA-PRO graced the cover of the Journal of Urology, giving doctors across the nation a deeper look into this groundbreaking procedure. 

The TULSA procedure uses magnetic resonance imaging (MRI) to guide doctors in delivering precise doses of ultrasound waves to diseased prostate tissue to destroy it while protecting the surrounding healthy tissue. It’s an incision-free process done using a probe inserted into the urethra. Because the typical treatments for prostate cancer involve surgery (removing the prostate), chemotherapy, and/or radiation, the side effects can be severe and permanent. Since the TULSA procedure affects only diseased tissue, it leaves the rest of the prostate (and the body) alone, giving men the chance to have a higher quality of life. 
The study showed TULSA “demonstrated effective tissue ablation and PSA reduction with low rates of toxicity and residual disease” after 12 months. You can read more about the research HERE.